Patients' perspectives on three-monthly administration of antipsychotic treatment with paliperidone palmitate - a qualitative interview study.
CONCLUSION: Switching from monthly to three-monthly injections with paliperidone palmitate seems to be experienced as advantageous for patients with schizophrenia.
PMID: 33151121 [PubMed - as supplied by publisher]
Source: Nordic Journal of Psychiatry - Category: Psychiatry Tags: Nord J Psychiatry Source Type: research
More News: Denmark Health | Health Management | Invega | Invega Sustenna | Men | Norway Health | Psychiatry | Schizophrenia | Study | Sweden Health | Women